{"id":16992,"date":"2019-04-01T15:51:59","date_gmt":"2019-04-01T13:51:59","guid":{"rendered":"http:\/\/mabdesign.fr\/early-drug-development-group-new-member\/"},"modified":"2023-10-17T10:48:20","modified_gmt":"2023-10-17T08:48:20","slug":"early-drug-development-group-new-member","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/","title":{"rendered":"Early Drug Development Group &#8211; new member"},"content":{"rendered":"<p><img decoding=\"async\" class=\"alignleft wp-image-5141 size-thumbnail\" src=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1-150x150.png\" alt=\"\" width=\"150\" height=\"150\" \/> Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.<\/p>\n<p><a href=\"https:\/\/www.e2dg.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Early Drug Development Group (E2DG)  offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.<\/p>\n","protected":false},"author":1,"featured_media":8946,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33,36,18],"tags":[],"class_list":["post-16992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-new-member","category-news","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Early Drug Development Group - new member - MabDesign<\/title>\n<meta name=\"description\" content=\"Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Early Drug Development Group - new member - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-01T13:51:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-17T08:48:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"2048\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Early Drug Development Group &#8211; new member\",\"datePublished\":\"2019-04-01T13:51:59+00:00\",\"dateModified\":\"2023-10-17T08:48:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/\"},\"wordCount\":42,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png\",\"articleSection\":[\"New member\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/\",\"name\":\"Early Drug Development Group - new member - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png\",\"datePublished\":\"2019-04-01T13:51:59+00:00\",\"dateModified\":\"2023-10-17T08:48:20+00:00\",\"description\":\"Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png\",\"width\":2048,\"height\":2048},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Early Drug Development Group &#8211; new member\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Early Drug Development Group - new member - MabDesign","description":"Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/","og_locale":"en_US","og_type":"article","og_title":"Early Drug Development Group - new member - MabDesign","og_description":"Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.","og_url":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/","og_site_name":"MabDesign","article_published_time":"2019-04-01T13:51:59+00:00","article_modified_time":"2023-10-17T08:48:20+00:00","og_image":[{"width":2048,"height":2048,"url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png","type":"image\/png"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Early Drug Development Group &#8211; new member","datePublished":"2019-04-01T13:51:59+00:00","dateModified":"2023-10-17T08:48:20+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/"},"wordCount":42,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png","articleSection":["New member","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/","url":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/","name":"Early Drug Development Group - new member - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png","datePublished":"2019-04-01T13:51:59+00:00","dateModified":"2023-10-17T08:48:20+00:00","description":"Early Drug Development Group (E2DG) offers professional assistance on drug development approaches, lead positioning, design of clinical studies and regulatory strategies to maximize the chance of your project success in oncology.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/Logo-E2DG-1.png","width":2048,"height":2048},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/early-drug-development-group-new-member\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Early Drug Development Group &#8211; new member"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16992"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16992\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/8946"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}